ARKG - ARK Genomic Revolution Multi-Sector ETF

NYSEArca - Nasdaq Real Time Price. Currency in USD
+0.35 (+1.22%)
At close: 3:53PM EST
Stock chart is not supported by your current browser
Previous Close28.65
Bid0.0000 x 900
Ask0.0000 x 900
Day's Range28.66 - 29.11
52 Week Range21.98 - 34.69
Avg. Volume134,990
Net Assets311.52M
PE Ratio (TTM)N/A
YTD Return20.59%
Beta (3Y Monthly)1.92
Expense Ratio (net)0.75%
Inception Date2014-10-30
Trade prices are not sourced from all markets
  • ETF Trends14 days ago

    New ETF Launches to Take Advantage of Growing Fintech Industry

    ARK Investment Management LLC (ARK), a New York-based adviser focused solely on disruptive innovation, today launched the ARK Fintech Innovation ETF (ARKF)–an ETF that capitalizes on the burgeoning fintech ...

  • Best & Worst Performing ETFs to Start 2019
    Zackslast month

    Best & Worst Performing ETFs to Start 2019

    We have highlighted some ETFs that are off to a good start in 2019 and some that have had a rough start.

  • ETF Trends2 months ago

    An ETF to Capture Biotech’s Breakthrough of the Century

    Health care investors should look to biotechnology sector-related ETFs that tap into some exciting new technologies that could translate into growth potential, such as CRISPR, biotech’s breakthrough of ...

  • ETF Trends3 months ago

    The Power of Genome Editing: What Investors Should Know

    The cost of sequencing a human genome has dropped significantly over the past years and genome editing is enabling new breakthroughs in medicine. On the upcoming webcast, The Power of Genome Editing: What ...

  • ETF Trends3 months ago

    Another Fintech ETF is Coming

    Ark Investment Management, the investment manager behind a series of unique Internet and technology exchange traded funds, could add to its ETF stable with a new fintech fund. “The product, the ARK Fintech ...

  • 3 DNA Stocks That Are on the Uptrend
    InvestorPlace3 months ago

    3 DNA Stocks That Are on the Uptrend

    The future of genetic medicine — and DNA stocks — is extremely bullish over the long term. But as is normal of any emerging technology, there will be plenty of bumps along the road. The good news is that those bumps will provide many opportunities to buy DNA stocks along the way.

  • 5 ETFs to Buy to Play the New Economy
    InvestorPlace4 months ago

    5 ETFs to Buy to Play the New Economy

    Unless you’ve been secretly living in a cave over the last few years, it’s easy to see how technology is changing our world. And it’s doing so at an exponential pace. Thanks to new advances in computing power, we are now able to do things that were considered science fiction only a few years ago. Leaps in machine learning, artificial intelligence and wireless connectivity are breathing life into new industries and disrupting old ones. The World Economic Forum has dubbed the movement the start of the Fourth Industrial Revolution.

  • Top & Flop Zones of Q3 & Their ETFs
    Zacks5 months ago

    Top & Flop Zones of Q3 & Their ETFs

    Some corners of ETF investing have performed exceptionally well in the third quarter while some are lagging.

  • Best ETFs & Stocks From the Top Sector of Q3
    Zacks5 months ago

    Best ETFs & Stocks From the Top Sector of Q3

    Healthcare was the best-performing sector of the third quarter, jumping 14.1% - its highest quarterly gain since the first quarter of 2013.

  • ETF Trends5 months ago

    What a Disruptive Innovation-Themed ETF Brings to the Table

    In an attempt to hone in on the potential opportunities, one should consider the criteria used to identity a disruptive innovation and look to an exchange traded fund strategy that adapts to the changes. On the recent webcast (available On Demand for CE Credit), How Investors Can Identify Disruptive Innovation and What it Can Add to a Portfolio, Catherine Wood, Chief Investment Officer and CEO of ARK Invest, explained three broad criteria to isolate a disruptive innovation platform. Disruptive innovations should enable rapid cost declines and economic tipping points, cut across sectors and geographies, and spawn further innovation.

  • InvestorPlace5 months ago

    4 Sector ETFs That Beat the Market in August

    The month of August was solid for Wall Street driven by the dual tailwinds of solid corporate earnings and a booming economy. The Dow Jones and the S&P 500 notched their best performances for the month since 2014, climbing 2.1% and 3%, respectively, while the Nasdaq Composite logged its best August since 2000, with gains of 5.7%. Notably, the S&P 500 topped a new milestone of 2,900.

  • Top and Flop ETFs of August
    Zacks6 months ago

    Top and Flop ETFs of August

    Inside the top and worst performing ETFs of August.

  • Genomic Revolution ETF (ARKG) Hits New 52-Week High
    Zacks6 months ago

    Genomic Revolution ETF (ARKG) Hits New 52-Week High

    This genomic revolution ETF hits a new 52-week high. Are more gains in store for this ETF?

  • 8 ETFs Up More Than 25% YTD
    InvestorPlace6 months ago

    8 ETFs Up More Than 25% YTD

    Braving all evils of emerging market and trade war fears, the S&P 500 index is on track to record the longest bull run in history. The benchmark is now up for 3,452 days and Aug 22 will mark 3,453 days since the S&P 500 hit its low of 666 on Mar 9, 2009. Since then, the index has risen more than 300% and is up more than 7% so far this year.Source: etf

  • ETF Trends6 months ago

    7 Healthcare ETFs Among Best Performing Defensive Picks This Year

    The healthcare sector and related ETFs have been among the best performing defensive plays this year as strong earnings and potential Trump administration actions on drug pricing drew greater investment ...

  • ETF Trends7 months ago

    Biotech ETFs Rally as Illumina Tops Q2 Expectations

    Biotechnology sector ETFs were among the best performers Tuesday, with Illumina (ILMN) shares surging after the genomics firm beat second-quarter expectations and raised its year-end outlook. Among the best performing ETFs of Tuesday, the Invesco Dynamic Biotech & Genome (PBE) increased 3.0%, ARK Genomic Revolution Multi-Sector ETF (ARKG) advanced 2.5% and iShares Nasdaq Biotechnology ETF (IBB) rose 2.0%. Evercore analyst Ross Muken said in that the Illumina stock story is "far too compelling to ignore," reports Allison Gatlin for Investor's Business Daily.

  • ETF Trends7 months ago

    ARK Genomics ETF Jumps 30.5% YTD

    The healthcare sector is home to some disruptive technologies and cutting-edge companies. That sentiment is highlighted by the ARK Genomic Revolution Multi-Sector ETF (NYSEArca: ARKG). ARKG actively invests ...

  • Leading Biotech Stocks Among This Top Sector's Biggest Bets
    Investor's Business Daily7 months ago

    Leading Biotech Stocks Among This Top Sector's Biggest Bets

    This year's top-performing health care funds are beating the broader market by a wide margin, thanks partly to leading biotech stocks.

  • ARK Funds Seek 'Disruptive Innovation' As 3 Make IBD Screen
    Investor's Business Daily7 months ago

    ARK Funds Seek 'Disruptive Innovation' As 3 Make IBD Screen

    ARK Invest is making the best of its few exchange traded funds. Of six total ETFs, three are performing well enough to make IBD's ETF Leaders screen.

  • ETF Trends7 months ago

    Trio of ARK ETFs Providing Stellar Returns

    If Noah was a fund manager and animals could invest, he’d put them on these ARK ETFs for stellar returns–ARK Genomic Revolution Multi-Sector ETF (NYSEArca: ARKG), ARK Innovation ETF (NYSEArca: ARKK) and ...

  • 4 Best-Performing Sector ETFs from May
    InvestorPlace9 months ago

    4 Best-Performing Sector ETFs from May

    The popular adage “Sell in May and Go Away” proved wrong this year as Wall Street is on track to log the best May in nine years. With just one trading session left to the month, the S&P 500 gained 3.3%, Dow Jones is up 3.1%, and Nasdaq Composite Index has moved up by 5.1% in May.Source: Shutterstock